Carlo Incorvaia

Ferrara, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Journal: International journal of molecular sciences

Published: May 12, 2015

Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a "Protective" Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients?

Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a "Protective" Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients?

Journal: Mediterranean journal of hematology and infectious diseases

Published: March 23, 2015

Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.

Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.

Journal: Mediators of inflammation

Published: July 23, 2013

Mechanism of inflammation in age-related macular degeneration.

Mechanism of inflammation in age-related macular degeneration.

Journal: Mediators of inflammation

Published: July 04, 2012

Genetic predictors of response to photodynamictherapy.

Genetic predictors of response to photodynamictherapy.

Journal: Molecular diagnosis & therapy

Published: September 15, 2011

Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Journal: Mediators of inflammation

Published: March 11, 2010

Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele.

Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele.

Journal: Current drug targets

Published: February 05, 2010

Predictive role of gene polymorphisms affecting thrombin-generation pathway in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

Predictive role of gene polymorphisms affecting thrombin-generation pathway in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

Journal: Recent patents on DNA & gene sequences

Published: June 13, 2009

Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.

Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.

Journal: Thrombosis research

Published: March 24, 2009

Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia.

Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia.

Journal: Ophthalmology

Published: February 17, 2009

Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

Journal: Pharmacogenomics

Published: December 24, 2008

Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.

Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.

Journal: European journal of ophthalmology

Published: November 07, 2008

Showing 1-12 of 20

Last Updated: 09/26/2026